Status: current, Defined. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2613790014 | Anti-tumor necrosis factor alpha agent (substance) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2616420014 | Anti-tumor necrosis factor alpha agent | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 2616421013 | Anti-tumour necrosis factor alpha agent | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 2622018016 | Anti-TNF drug | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3520618011 | Tumor necrosis factor alpha inhibitor | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3520691016 | Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3520863010 | Substance with tumor necrosis factor alpha inhibitor mechanism of action | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3636179014 | Tumour necrosis factor alpha inhibitor | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3636180012 | Substance with tumour necrosis factor alpha inhibitor mechanism of action | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tumour necrosis factor alpha inhibitor | Is a | Drug or medicament | true | Inferred relationship | Some | ||
| Tumour necrosis factor alpha inhibitor | Is a | Biological agent | false | Inferred relationship | Some | ||
| Tumour necrosis factor alpha inhibitor | Is a | Immunomodulator | true | Inferred relationship | Some | ||
| Tumour necrosis factor alpha inhibitor | Is a | Anti-inflammatory agent | false | Inferred relationship | Some | ||
| Tumour necrosis factor alpha inhibitor | Has disposition | Tumour necrosis factor alpha inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Certolizumab pegol | Is a | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Golimumab | Is a | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Adalimumab | Is a | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Infliximab | Is a | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Etanercept | Is a | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Tumour necrosis factor alpha inhibitor-containing product | Has active ingredient | True | Tumour necrosis factor alpha inhibitor | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR